Sexual satisfaction in men with erectile dysfunction: Correlates and potential predictors

Journal of Sexual Medicine

Volumn 7, Issue 1 PART 1, 2010, Pages 203-215

  Althof, Stanley E ^a   Buvat, Jacques ^b   Gutkin, Stephen W ^c   Belger, Mark ^d   Stothard, Diane R ^d   Fugl Meyer, Axel R ^e  

^a Center for Marital and Sexual Health of South Florida   (United States)

^b Centre Etude et de Traitement de la Pathologie de l'Appareil   (France)

^c Rete Biomedical Communications Corp   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

Drug therapy; Erectile dysfunction; Phosphodiesterases; Satisfaction; Sexual activity; Treatment outcome

Indexed keywords

INSULIN; PLACEBO; TADALAFIL;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; VASCULAR DISEASE;

EID: 74049088983     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01554.x     Document Type: Article

References (43)

1. Sanchez-Cruz JJ, Cabrera-Leon A, Martin-Morales A, Fernandez A, Burgos R, Rejas J. Male erectile dysfunction and health-related quality of life. Eur Urol 2003, 44:245-53.
2. Fugl-Meyer K, Fugl-Meyer AR. Sexual disabilities are not singularities. Int J Impot Res 2002, 14:487-93.
3. Strand J, Wise TN, Fagan PJ, Schmidt CW. Erectile dysfunction and depression: Category or dimension? J Sex Marital Ther 2002, 28:175-81.
4. Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998, 52:848-52.
5. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998, 60:458-65.
6. Makhlouf A, Parker A, Niederberger CS. Depression and erectile dysfunction. Urol Clin North Am 2007, 34:vii-74.
7. McCabe MP. Relationship factors in the development and maintenance of ED: Implications for treatment effectiveness. J Sex Med 2008, 5:1795-804.
8. Tan HM, Low WY, Ng CJ, Chen KK, Sugita M, Ishii N, Marumo K, Lee SW, Fisher W, Sand M. Prevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian men: The Asian Men's Attitudes to Life Events and Sexuality (MALES) study. J Sex Med 2007, 4:1582-92.
9. Holden CA, McLachlan RI, Pitts M, Cumming R, Wittert G, Agius PA, Handelsman DJ, de Kretser DM. Men in Australia Telephone Survey (MATeS): A national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 2005, 366:218-24.
10. Klotz T, Mathers M, Klotz R, Sommer F. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)? Int J Impot Res 2005, 17:2-4.
11. Son H, Park K, Kim SW, Paick JS. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Asian J Androl 2004, 6:117-20.
12. Fisher WA, Rosen RC, Eardley I, Niederberger C, Nadel A, Kaufman J, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: Understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med 2004, 1:150-60.
13. Baldwin K, Ginsberg P, Harkaway RC. Under-reporting of erectile dysfunction among men with unrelated urologic conditions. Int J Impot Res 2003, 15:87-9.
14. Mulhall J, King R, Glina S, Hvidsten K. Importance of and satisfaction with sex among men and women worldwide: Results of the Global Better Sex Survey. J Sex Med 2008, 5:788-95.
15. Carson C, Giuliano F, Goldstein I, Hatzichristou D, Hellstrom W, Lue T, Montorsi F, Munarriz R, Nehra A, Porst H, Rosen R. The " effectiveness" scale-Therapeutic outcome of pharmacologic therapies for ED: An international consensus panel report. Int J Impot Res 2004, 16:207-13.
16. Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997, 9:141-8.
17. NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA 1993, 270:83-90. National Institutes of Health
18. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, Vardi Y. EAU guidelines on erectile dysfunction: An update. Eur Urol 2006, 49:806-15.
19. Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial. Urology 2003, 62:121-5.
20. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49:822-30.
21. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998, 338:1397-404.
22. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses. J Urol 2002, 168:1332-6.
23. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H. Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: Results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. Urology 2003, 61:8-14.
24. Fugl-Meyer A, Althof S, Buvat J, Paget MA, Sotomayor M, Stothard D. Aspects of sexual satisfaction in men with erectile dysfunction: A factor analytic and logistic regression approach. J Sex Med 2009, 6:232-42.
25. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999, 54:346-51.
26. Lemeshow S, Hosmer DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982, 115:92-106.
27. Hosmer DW, Wang CY, Lin IC, Lemeshow S. A computer program for stepwise logistic regression using maximum likelihood estimation. Comput Programs Biomed 1978, 8:121-34.
28. Seftel AD. From aspiration to achievement: Assessment and noninvasive treatment of erectile dysfunction in aging men. J Am Geriatr Soc 2005, 53:119-30.
29. Rosen RC, Shabsigh R, Kuritzky L, Wang WC, Sides GD. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: A retrospective pooled analysis of data from randomized, placebo-controlled clinical trials. Curr Med Res Opin 2005, 21:1701-9.
30. Lewis JH, Rosen R, Goldstein I. Patient education series. Erectile dysfunction. Nursing 2005, 35:64.
31. El-Khiat Y, Ghazi S, Allam A, Khawaja M, Belger M, Tamer M, Kopernicky V. Psychosocial impact and effectiveness of tadalafil among treatment-naive and previously treated men with erectile dysfunction in Saudi Arabia and other Gulf-region countries. Curr Med Res Opin 2008, 24:1965-73.
32. Gralla O, Knoll N, Fenske S, Spivak I, Hoffmann M, Ronnebeck C, Lenk S, Hoschke B, May M. Worry, desire, and sexual satisfaction and their association with severity of ED and age. J Sex Med 2008, 5:2646-55.
33. Korfage IJ, Pluijm S, Roobol M, Dohle GR, Schröder FH, Essink-Bot ML. Erectile dysfunction and mental health in a general population of older men. J Sex Med 2009, 6:505-12.
34. Stamogiannou I, Grunfeld EA, Denison K, Muir G. Beliefs about illness and quality of life among men with erectile dysfunction. Int J Impot Res 2005, 17:142-7.
35. Althof SE. When an erection alone is not enough: Biopsychosocial obstacles to lovemaking. Int J Impot Res 2002, 14(1):S99-S104. suppl
36. Speckens AE, Kattemölle MR, Hengeveld MW, Lycklama à Nijeholt AB, Van Hemert AM, Hawton KE. A prospective long-term follow-up study of patients evaluated for erectile dysfunction: Outcome and associated factors. Int J Impot Res 1995, 7:101-10.
37. Schneidewind-Skibbe A, Hayes RD, Koochaki PE, Meyer J, Dennerstein L. The frequency of sexual intercourse reported by women: A review of community-based studies and factors limiting their conclusions. J Sex Med 2008, 5:301-35.
38. Laumann EO, Paik A, Glasser DB, Kang JH, Wang T, Levinson B, Moreira ED, Nicolosi A, Gingell C. A cross-national study of subjective sexual well-being among older women and men: Findings from the Global Study of Sexual Attitudes and Behaviors. Arch Sex Behav 2006, 35:145-61.
39. Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K, Stecher V, Seftel AD. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999, 53:793-9.
40. Conaglen HM, Conaglen JV. Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: The partners' preference study. J Sex Med 2008, 5:1198-207.
41. Althof SE, Eid JF, Talley DR, Brock GB, Dunn ME, Tomlin ME, Natanegara F, Ahuja S. Through the eyes of women: The partners' perspective on tadalafil. Urology 2006, 68:631-5.
42. Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005, 2:675-84.
43. Shabsigh R, Anastasiades A, Cooper KL, Rutman MP. Female sexual dysfunction, voiding symptoms and depression: Common findings in partners of men with erectile dysfunction. World J Urol 2006, 24:653-6.